Masimo | MASI - Ebit

Aktienkurs
178.24
Täglich Wechseln
-0.46 -0.26%
Monatlich
1.71%
Jährlich
7.49%
Q1 Prognose
170.19




Ebit Veränderung Datum
Abbott USD 2.54B 358M 2025-12
Accuray USD 11.38M 12.71M 2024-09
Align Technology USD 224.71M 40.06M 2025-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
General Electric Aerospace USD 1.68B 429M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 13.71M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
Masimo USD 83.9M 200K 2025-12
Medtronic USD 1.74B 40M 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
Owens Minor USD 814K 28.08M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12